Elixinol Wellness Limited
ELLXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $15 | $8 | $7 | $9 |
| % Growth | 80.9% | 17.2% | -24.4% | – |
| Cost of Goods Sold | $9 | $5 | $10 | $16 |
| Gross Profit | $6 | $3 | -$3 | -$6 |
| % Margin | 37.7% | 41.4% | -46.3% | -67% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $6 | $4 | $13 |
| SG&A Expenses | $8 | $8 | $7 | $17 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $4 |
| Other Operating Expenses | $3 | $2 | $0 | -$7 |
| Operating Expenses | $11 | $10 | $7 | $9 |
| Operating Income | -$5 | -$6 | -$10 | -$16 |
| % Margin | -34.1% | -78.1% | -141.8% | -167.2% |
| Other Income/Exp. Net | -$0 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$5 | -$8 | -$11 | -$17 |
| Tax Expense | -$4 | $0 | $0 | -$0 |
| Net Income | -$2 | -$8 | -$11 | -$17 |
| % Margin | -11.5% | -90.8% | -149.8% | -182.3% |
| EPS | -0.011 | -0.099 | -0.026 | -0.042 |
| % Growth | 88.8% | -280.4% | 38.2% | – |
| EPS Diluted | -0.011 | -0.099 | -0.026 | -0.042 |
| Weighted Avg Shares Out | 155 | 76 | 406 | 405 |
| Weighted Avg Shares Out Dil | 155 | 76 | 406 | 405 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$4 | -$7 | -$9 | -$15 |
| % Margin | -27.4% | -82.3% | -131.6% | -161.9% |